WilmerHale Advises Underwriters in MacroGenics Public Offering

WilmerHale Advises Underwriters in MacroGenics Public Offering

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

WilmerHale represented the underwriters in the follow-on offering of 6,325,000 shares of common stock of MacroGenics, Inc., at a price to the public of $20.00 per share, for aggregate gross proceeds of $126.5 million. This reflects the full exercise of the underwriters’ option to purchase additional shares of common stock. The offering priced on February 12, 2019 and closed on February 15, 2019.

The WilmerHale team consisted of Lisa Firenze, Scott Lunin, Chip McCorkle and Arwa Alali, with support from Julie Hogan Rodgers, Colleen Superko, Bruce Manheim and Lily Wound.


Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel